Transcript segment

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

1. 2026-04-10 09:00 Christina Salazar open
   Okay. Have you ever done any work with any laboratories in Sri Lanka?
2. 2026-04-10 09:00 Ralph S. Baric open
   Sri Lanka.
3. 2026-04-10 09:00 Christina Salazar open
   Mm-hmm.
4. 2026-04-10 09:00 Ralph S. Baric open
   A good collaborator that I have, who is Aravinda de Silva, who came from Sri Lanka, has connections there. And I've been funded with Aravinda and Eva Harris for a variety of dengue research and Zika research. So serum samples, we've gotten serum samples from both Sri Lanka and from the Philippines and from Nicaragua to do studies on flavivirus evolution, and identifying major DC.Scheduling@LexitasLegal.com neutralizing epitopes for the development of therapeutic antibodies in vaccines. But I have never been to Sri Lanka or the Philippines. I have been to Nicaragua for a meeting with a P01 that I had, and currently have with Eva Harris, that studies dengue virus pathogenesis. It studied dengue virus pathogenesis in children in Nicaragua for the past 20-some years. It's the longest-running natural infection cohort on dengue virus, which has identified a large number of important features associated with what drives pathogenesis, and has informed the vaccine development. Currently we're funded with Aravinda to develop next12 generation protein-designed vaccines against dengue.
5. 2026-04-10 09:00 Christina Salazar
   And what agency funds the work that you had done --
6. 2026-04-10 09:00 Ralph S. Baric open
   NIH.
7. 2026-04-10 09:00 Christina Salazar open
   -- with Sri Lanka?
8. 2026-04-10 09:00 Ralph S. Baric open
   Yes.
9. 2026-04-10 09:00 Christina Salazar open
   Okay. Going back to PREEMPT, did you ever receive any funding through the PREEMPT program, either as a direct awardee, subcontractor, subawardee?

Full conversation →